3 ms·
It seems that you didn't even read three paragraphs into the article: "At times, McKinsey consultants helped those drugmaker clients fend off costly FDA oversi
by teachrdan 5y ago
It seems that you didn't even read three paragraphs into the article:
"At times, McKinsey consultants helped those drugmaker clients fend off costly FDA oversight — even as McKinsey colleagues assigned to the FDA were working to bolster the agency’s regulation of the pharmaceutical market. In one instance, for example, McKinsey consultants helped Purdue and other opioid producers push the FDA to water down a proposed opioid-safety program. The opioid producer ultimately succeeded in weakening the program, even as overdose deaths mounted nationwide."
McKinsey was actively helping opioid manufacturers minimize government oversight. The misconduct in question by McKinsey isn't hypothetical.
- jollybean 5y agoYou've provided evidence that supports my position. Different McKinsey teams were hired by different entities to do different things. To the extent that those teams are not related or coordinating, that's understandable and not a breach of ethics. An Accenture division can be helping to the IRS build tax compliance software while another division help companies write tax minimization software. There are only a small number of 'Big Accounting' firms, and they all have overlapping interests. Banks to similarly. McKinsey, Goldman, Accenture, all the big accounting firms are always working with 'Big Pharma' and 'Government' at the same time and all of the parties know this. While we do need to be wary and cautious about backchannel information passing etc. - the notion that there's a breach of public interest as it is being presented is hyperbole.
- kesselvon 5y agoWatering down an opioid safety program when the negative externalities of pushing opioids onto patients was very apparent is definitely not ethical.